Development Of Novel Remyelination Promoting Therapeutics For Multiple Sclerosis And Other Neurological Disorders

Project Details

StatusFinished
Effective start/end date28/03/1931/05/22

Funding

  • UK industry, commerce and public corporations: £579,775.00